Active ingredient
Voxelotor
3 finished FDA listings contain Voxelotor as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- VOXELOTOR
- Dosage forms
- Tablet, Film Coated, Tablet, For Suspension
- Routes
- Oral
- Manufacturers / labelers
- 1
- Strengths listed
- 300 mg/1 · 500 mg/1
- Brand names in FDA listings
- Oxbryta
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 2265678
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 213137 | GLOBAL BLOOD THERAPS | 2019-11-25 | 2 |
| NDA 216157 | GLOBAL BLOOD THERAPS | 2021-12-17 | 1 |
Official labeling on DailyMed
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.